Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome

(NASDAQ:BIIB) – Durable reductions in seizures and continuing improvements in cognition and behavior through 3 years in patients who continued to receive zorevunersen in the open-label extension st...

What are the expected timelines for regulatory submission and possible approval, and how might that shape the long‑term growth prospects for Biogen and Stoke Therapeutics? How does Zorevunersen’s efficacy and safety profile compare to existing and pipeline treatments for Dravet syndrome and other epilepsies? What potential impact could the 3‑year open‑label extension data on Zorevunersen have on Biogen’s (BIIB) stock price in the short term?
Symbol: BIIB
Clinical trials
15 days ago
Read more globenewswire

Gaming & Leisure Properties Furthers Tribal Partnership With Accretive Long-Term Financing for Caesars Republic Sonoma County

(NASDAQ:GLPI) WYOMISSING, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI”) today announced its $225 million commitment to serve as the lead real...

How does this new tribal partnership compare to GLPI's existing deals and to financing activities of competing gaming‑property REITs? What are the projected revenue and profit contributions from the Caesars Republic Sonoma County integrated resort, and over what timeline? How will GLPI's $225 million financing commitment impact its balance sheet, cash flow, and leverage ratios?
Symbol: GLPI
Financing
15 days ago
Read more globenewswire

Baker Hughes Selected by Fervo Energy to Deliver Geothermal Power Generation Equipment for Innovative New Power Plants

(NASDAQ:BKR) HOUSTON and LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday an award from Fervo Energy Company, the leader in n...

How does this geothermal partnership position Baker Hughes relative to competitors in the renewable energy equipment market? What is the expected timeline for the Cape Phase II plants to become operational and impact cash flow? How will Baker Hughes' earnings be impacted by the Fervo Energy ORC equipment contract?
Symbol: BKR
Energy
15 days ago
Read more globenewswire

Fury Announces Results of Preliminary Economic Assessment for the Eau Claire Gold Deposit with a Base Case After-Tax NPV (5%) of $554M and After-Tax IRR of 41%

(FURY) TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce results from a preliminary economic asses...

How does the Eau Claire project's economics compare with other junior gold projects in Quebec and with Fury’s existing assets, and what impact might this have on the company's market positioning and future growth prospects? What are the key sensitivities (gold price, capital cost, operating cost, discount rate) and the financing requirements (including potential dilution) needed to fund the projected capital expenditures? How will the $554 M after‑tax NPV and 41% IRR affect Fury’s valuation and implied share price versus current market levels?
Symbol: FURY
Mining
15 days ago
Read more globenewswire

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy

(JADE) First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101

How does JADE101’s mechanism and trial design differ from competitor programs, and what are the implications for future regulatory and partnership opportunities? What is the estimated market size for an anti‑APRIL therapy in IgA nephropathy compared to existing treatments and peers? When is the expected data readout from this Phase 1 trial and how might it influence near‑term share price?
Symbol: JADE
Clinical trials
15 days ago
Read more globenewswire

Apollo to Proceed with 5-for-1 Share Consolidation

(APGO) VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) --  Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce that, furt...

What are the short‑term and long‑term implications for existing shareholders, including potential tax or dilution effects? Will the consolidation affect the company's index eligibility and liquidity on major exchanges? What is the expected impact of the 5-for-1 share consolidation on APGO's price‑to‑earnings multiple and market price?
Symbol: APGO
Share split
15 days ago
Read more globenewswire